AzTrials
AzTrials

Chronic Low Back PainNCT03850717

Safety of Acupuncture Treatments for Chronic Low Back Pain in Older Adults

An observational study of Chronic Low Back Pain and Older Adults, run by McLean Center for Complementary and Alternative Medicine, PLC at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Acupuncture, along with other complementary and integrative treatments, is commonly used as a complementary or integrative therapy when treating a multitude of pain complaints, including chronic low back pain(CLBP). It has been practiced as a non-pharmacological therapy in the United States over one hundred years. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Chronic Low Back Pain, Older Adults
What is being tested?
acupuncture
Type of treatment
Medical device
How many people
500 participants
Where
1 siteUnited States
Study dates
31 Dec 2013to 20 Feb 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: * age: 65 years or older; * both genders; * white, black and other nationalities. * with chronic low back pain. * Had at least one acupuncture treatment in McLean Center for Complementary and Alternative Medicine, PLC during the period of Dec. 31, 2013 to Dec.30, 2018.

Who may be able to join

  • Age: 65-80 years old.
  • CLBP is defined as a back pain problem that has persisted for at least 3 months or has resulted in pain on at least half the days in the past 6 months.
  • A minimum pain intensity score of 4 out of 10 on a visual analog scale (0 = no pain, 10 = most severe pain);
  • ability of the participant to fully understand the trial procedure and the risks involved, communicate with the examiner, and comply with the protocol;
  • provision of written informed consent for participation.

Who cannot join

  • Age: younger than 65.
  • Pain mainly at legs;
  • a history of spinal surgery;
  • hip osteoarthritis; progressive neurological deficit or severe psychiatric or psychological disorders;
  • serious spinal disorders, such as metastatic cancer, vertebral fracture, spinal infection, and inflammatory spondylitis;
  • other contraindications for treatment, such as clotting disorders, use of anticoagulants or chemotherapy medications, and seizure disorders;
Show all 10Show fewer
  • presence of a device that could be affected by electromagnetic fields, such as a pacemaker;
  • use of medications that could affect the trial results, such as corticosteroids and anticonvulsants, within the last week;
  • participation in other clinical trials;
  • ineligibility judged by a researcher.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • McLean Center for Complementary and Alternative Medicine,PLC

    Vienna, Virginia, 22182

Other trials in United States

About this study

Official title: Retrospective Study on Safety of Acupuncture Treatments for Chronic Low Back Pain in 65 Years and Older in an Acupuncture Clinic From 2013 to 2018.

Acupuncture, along with other complementary and integrative treatments, is commonly used as a complementary or integrative therapy when treating a multitude of pain complaints, including chronic low back pain(CLBP). It has been practiced as a non-pharmacological therapy in the United States over one hundred years. Integrative pain management pilot programs have demonstrated impressive reductions in medications use, emergency room visits, and annual costs of healthcare. In fact, CLBP is one of the most common conditions treated in an acupuncturist's daily schedule. Based on acupuncturists' practice, CLBP has accounted for about 12% of patient visits in recent years. Most CLBP patients who come to acupuncturists' clinic are older adults. Investigators will retrospectively check the safety of acupuncture, i.e.side effects or adverse effects of acupuncture during treatments of CLBP in older adults in past 5 years.

Read the detailed description

Back pain, especially low back pain (LBP), is one of the most common conditions for Americans to visit their physicians and therapists. In a recent survey, chronic neck and/or back pain was found to affect 54% of American adults in 2017. Another survey found that 32.5% of those 65 years and older suffer from back pain. Chronic low-back pain (CLBP) is defined by National Institutes of Health (NIH) as pain at the low back that persists for 12 weeks (3 months) or longer, even after an initial injury or underlying cause of acute low-back pain has been treated. About 20% of people affected by acute low-back pain develop CLBP with persistent symptoms at 1 year.

The inclusion criteria of CLBP in older adults:

Age: 65-80 years old. CLBP is defined as a back pain problem that has persisted for at least 3 months or has resulted in pain on at least half the days in the past 6 months. A minimum pain intensity score of 4 out of 10 on a visual analog scale (0 = no pain, 10 = most severe pain); ability of the participant to fully understand the trial procedure and the risks involved, communicate with the examiner, and comply with the protocol; provision of written informed consent for participation.

The exclusion criteria of CLBP in older adults:

Age: younger than 65. Pain mainly at legs; a history of spinal surgery; hip osteoarthritis; progressive neurological deficit or severe psychiatric or psychological disorders; serious spinal disorders, such as metastatic cancer, vertebral fracture, spinal infection, and inflammatory spondylitis; other contraindications for treatment, such as clotting disorders, use of anticoagulants or chemotherapy medications, and seizure disorders; presence of a device that could be affected by electromagnetic fields, such as a pacemaker; use of medications that could affect the trial results, such as corticosteroids and anticonvulsants, within the last week; participation in other clinical trials; ineligibility judged by a researcher.

For acupuncture in CLBP in older adults, one of public concerns is the safety of acupuncture. A thorough systematic review by Chan, et al. published in 2017 concludes that while some adverse events are reported, "all the reviews have suggested that adverse events are rare and often minor." These findings are consistent with prior studies. Some severe adverse events such as brain stem piercing, spinal lesions, infectious disease transmission, organ puncture, needle breaking and migrating, and death have been documented in other countries, but may be associated with provider competence and training, and could be avoided with sufficient regulations determining appropriate clinicians. Most of such severe adverse events are not within the scope related to the treatment in CLBP. There is no any specific acupuncture safety observation in treating CLBP in seniors. The aim of current study is retrospectively check all information documented related to side effects or adverse effects of acupuncture during treatments of CLBP in older adults in past 5 years. The treatments of acupuncture for CLBP are:

  1. Acupuncture points (acupoints) or locations Use local points, in or near pain area, plus distant points. The local acupoints include Shenshu (BL23), Qihaishu (BL24), Dachangshu (BL25), and Guanyuanshu (BL26). These four pairs of points are located beside the L2-L5 spinal nerve foramen, while the CLBP may be related to L3-L5 nerves, erector spinae and associated fascia. Also use Yaoyan (EX-B-7). If the pain point (also called "tender point," "Ashi point" or "trigger point") is not located exactly at a traditional point location, consider the use of the tender point, instead of traditional point locations. If there are pain points (Ashi or trigger points) at gluteal muscles or the sacroiliac joint, add local points there as well. In clinical practice, 8-10 needles are used for these acupoints. The distant acupoints include Zusanli (ST36), Weizhong (BL40), Yanglingquan (GB34), Fengshi (GB31), and Sanyinjiao (SP6). I use up to 3 pairs of distal acupoints.
  2. Needle sizes and needling technique Use 1.5-2.0 cun (40-50 mm), 30 or 32 gauge (G; 0.30 or 0.25 mm in diameter) filiform acupuncture needles. Occasionally, use 3.0 cun (75 mm), G30 needles for the gluteal muscle area (Cloud \& Dragon, LEKON or EXPERT Traditional Acu Needles, manufactured and distributed by C.A.I. Corporation, USA). Prefer to treat patients in the prone position, inserting needles vertically (or slightly obliquely to the spinal foramen) about 1-1.5 cun (40-50 mm) deep, depending on patient size.
  3. Inducing Deqi or not Use light Deqi technique [11]. That is, after inserting the needles, patients will feel some pressure or soreness at the local soft tissue area; at the same time, the acupuncturist will feel a pulling or pressure sensation from the inserted needle. Generally, do not use electric acupuncture for older adults with CLBP, due to the fact that such patients may have deficiency conditions. But use an infrared lamp to treat the low-back area during the acupuncture session. The acupuncture treatment lasts 45 min. After that, use light- to moderate-force suction cupping at the low-back pain area for 3-5 min.
  4. Treatment duration Ideal treatment frequency or duration is 16-24 sessions: twice a week for 8-10 weeks, then once a week for 4 weeks, if possible. Most senior patients only have Medicare insurance, and in some cases, supplemental insurance; Medicare and supplemental insurance generally do not cover acupuncture. In the real world, senior CLBP patients have to pay out-of-pocket (give them some discount). Senior patients with CLBP may only choose to pay for 8-10 sessions, which may limit acupuncture's effectiveness.

One characteristic of CLBP in senior patients is that it may be due to a deficiency condition ("kidney deficiency" or "qi-blood deficiency"), which makes CLBP in seniors more difficult to treat than in younger adults. For this reason, one strategy of mine is using tonifying or strengthening acupoints: BL23, ST36, SP6, etc. Another strategy is to encourage patients to get more acupuncture sessions, such as 16-20 sessions, or say, after extensive treatments, then to get some tuning up sessions. In current investigator's practice, add Shenting (GV24), Yintang or ear Shenmen to calm patients' spirit, and help get a quicker effect in treating the older adults'CLBP.

In the United States, there has been no large-scaled acupuncture clinical trial of CLBP in older adults, especially focused on the real-world practice, therefore, there was no any safety evaluation study of acupuncture during the treatments of CLBP in older adults. In current studies, the investigators will check the CLBP senior (>65 years old) patients' files in past 5 years and find the detail safety information, i.e.side effects or adverse effects.

Being tested
acupuncture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • acupunctureDevice

    insert in filiform needles into skin and other soft tissue to treat the illness or disorders

Study groups in NCT03850717
Study groupRoleWhat they receive
Traditional Chinese AcupunctureUse traditional acupuncture, stronger, deeper, "harder-acupuncture"
Receives: Device: acupuncture
Japanese AcupunctureUse traditional shallow, lighter acupuncture, "softer-acupuncture"
Receives: Device: acupuncture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The rate of participates with bleeding

    bruise in 3 levels: diameter<5mm, 6-10mm, >11mm

    Measured: 2013-2018

Secondary outcomes (4)
  1. The rate of participates with pain

    3 levels: slight(<score 3), moderate (score 4-6), severe (score >7)

    Measured: 2013-2018

  2. The rate of participates with fainting

    3 levels: light-headed, slight faint, fainted.

    Measured: 2013-2018

  3. The rate of participates with organ injury

    Any organ injury-lung, heart, brain, liver, kidney, etc.

    Measured: 2013-2018

  4. The rate of participates caused Infection

    any infection related to acupuncture

    Measured: 2013-2018

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Feb 2019
  2. Study start31 Dec 2013
  3. Primary completion30 Dec 2018
  4. Study completion20 Feb 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03850717
Sponsor's protocol ID
ATCMA 201901
Status last verified
Feb 2019
First submitted
20 Feb 2019
Last updated
25 Feb 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: protect patients' personal information

Publications

  • Fan AY, Ouyang H, Qian X, Wei H, Wang DD, He D, Tian H, Gong C, Matecki A, Alemi SF. Discussions on real-world acupuncture treatments for chronic low-back pain in older adults. J Integr Med. 2019 Mar;17(2):71-76. doi: 10.1016/j.joim.2019.01.005. Epub 2019 Jan 26.

    PubMed 30738771
  • Chan MWC, Wu XY, Wu JCY, Wong SYS, Chung VCH. Safety of Acupuncture: Overview of Systematic Reviews. Sci Rep. 2017 Jun 13;7(1):3369. doi: 10.1038/s41598-017-03272-0.

    PubMed 28611366

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Low Back Pain and Older Adults, run by McLean Center for Complementary and Alternative Medicine, PLC at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The rate of participates with bleeding (time frame: 2013-2018). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03850717, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in